Founded with a mission to revolutionize cardiovascular health, PhysioWave is a medical device company that focuses on developing innovative technologies to measure Pulse Wave Velocity (PWV). The company's core vision is to improve cardiovascular risk prediction and management by integrating PWV measurements with traditional risk factors. Their flagship product, PhysioWave Pro™, is the world's first FDA-cleared scale-based device designed to assess arterial stiffness, providing a more accurate and early identification of cardiovascular disease risks.
PhysioWave has garnered attention from notable figures in the medical and investment communities. The company's achievements include FDA clearance for their groundbreaking device and endorsements from leading health organizations such as the American Heart Association and the American College of Cardiology. These endorsements highlight the significant impact PhysioWave's technology has on enhancing cardiovascular health diagnostics and patient outcomes.
